Case Reports
doi: 10.1097/CAD.0b013e3280e9496d.
Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature
Affiliations
- PMID: 17667605
- DOI: 10.1097/CAD.0b013e3280e9496d
Item in Clipboard
Case Reports
Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature
Anticancer Drugs.
2007 Sep.
Abstract
We report a 59-year-old woman diagnosed with metastasic colorectal cancer who developed immune hemolytic anemia during FOLFOX chemotherapy (oxaliplatin/leucovorin/5-fluorouracil). Immunohematologic studies demonstrated that immune hemolysis was oxaliplatin-mediated. On the basis of this case and in a review of the literature in which 13 cases of previously reported oxaliplatin-induced immune cytopenia have been identified, we suggest some clinical clues regarding the use of oxaliplatin in cancer patients.
Similar articles
-
Anaphylactic reaction to oxaliplatin: a case report.Am J Gastroenterol. 1999 Nov;94(11):3387-8. doi: 10.1111/j.1572-0241.1999.3387a.x. Am J Gastroenterol. 1999. PMID: 10566767 No abstract available.
-
Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.Anticancer Drugs. 2007 Mar;18(3):297-300. doi: 10.1097/CAD.0b013e3280102f4b. Anticancer Drugs. 2007. PMID: 17264762
-
FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.Cancer Invest. 2008 Jul;26(6):610-4. doi: 10.1080/07357900701781747. Cancer Invest. 2008. PMID: 18584352 Review.
-
A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.Anticancer Drugs. 2007 Oct;18(9):1103-7. doi: 10.1097/CAD.0b013e3281722010. Anticancer Drugs. 2007. PMID: 17704661 Clinical Trial.
-
Review of oxaliplatin: an active platinum agent in colorectal cancer.Int J Clin Pract. 2000 Jul-Aug;54(6):399-402. Int J Clin Pract. 2000. PMID: 11092115 Review.
Cited by
-
Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension.Sci Rep. 2021 Oct 28;11(1):21246. doi: 10.1038/s41598-021-00692-x. Sci Rep. 2021. PMID: 34711891 Free PMC article.
-
Carboplatin Induced Fatal Autoimmune Hemolytic Anemia: First Reported Case.World J Oncol. 2010 Aug;1(4):173-175. doi: 10.4021/wjon234w. Epub 2010 Aug 29. World J Oncol. 2010. PMID: 29147201 Free PMC article.
-
Oxaliplatin-Induced Neuropathy: Genetic and Epigenetic Profile to Better Understand How to Ameliorate This Side Effect.Front Mol Biosci. 2021 May 7;8:643824. doi: 10.3389/fmolb.2021.643824. eCollection 2021. Front Mol Biosci. 2021. PMID: 34026827 Free PMC article. Review.
-
Acute renal failure related to oxaliplatin-induced intravascular hemolysis.Med Oncol. 2010 Dec;27(4):1425-6. doi: 10.1007/s12032-009-9263-3. Epub 2009 Jun 30. Med Oncol. 2010. PMID: 19565364
-
New in vitro highly cytotoxic platinum and palladium cyanoximates with minimal side effects in vivo.J Inorg Biochem. 2020 Jul;208:111082. doi: 10.1016/j.jinorgbio.2020.111082. Epub 2020 May 6. J Inorg Biochem. 2020. PMID: 32413634 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
